HR 5122 · 114th Congress 2015–2017, ended

To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Introduced Apr 29, 2016 Originated House Sponsor Larry Bucshon R-IN

Fact sheet Spreadsheet

Latest action · May 12, 2016 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedApr 29, 2016
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).

Cosponsors 22

Members who signed on, in the order they did. Signatures ran from Apr 29, 2016 to Sep 21, 2016; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-LACharles W. Boustany, Jr.OriginalApr 29, 2016
R-ILJohn ShimkusOriginalApr 29, 2016
R-ILRobert J. DoldOriginalApr 29, 2016
R-GATom PriceOriginalApr 29, 2016
D-NEBrad AshfordJun 28, 2016
R-WACathy McMorris RodgersJul 13, 2016
R-MNErik PaulsenJul 13, 2016
R-ORGreg WaldenJul 13, 2016
R-FLGus M. BilirakisJul 13, 2016
R-LAJohn FlemingJul 13, 2016
R-OHPatrick J. TiberiJul 13, 2016
R-GARick W. AllenJul 13, 2016
R-ALRobert B. AderholtJul 13, 2016
R-OHRobert E. LattaJul 13, 2016
R-INSusan W. BrooksJul 13, 2016
R-OKTom ColeJul 13, 2016
R-NYTom ReedJul 13, 2016
D-CAPete AguilarJul 14, 2016
R-VABarbara ComstockSep 9, 2016
R-NJLeonard LanceSep 9, 2016
R-CADevin NunesSep 13, 2016
R-KYBrett GuthrieSep 21, 2016

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Apr 29, 2016
Health Subcommittee
Referred May 6, 2016
HouseWays and Means Committee
Referred Apr 29, 2016
Health Subcommittee
Referred May 12, 2016

Actions 4

Everything that happened, newest first.

  1. May 12, 2016Referred to the Subcommittee on Health.
  2. May 6, 2016Referred to the Subcommittee on Health.
  3. Apr 29, 2016Introduced in House
  4. Apr 29, 2016Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseLists H2150H.R. 5122–5163—Apr 29, 2016

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimate

  1. Oct 4, 2016H.R. 5122, a bill to prohibit further action on the proposed rule regarding testing of Medicare Part B prescription drug modelsAs introduced on April 29, 2016

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: Article 1, Section 8, Clause 1 of the United States Constitution

The sponsor’s statement, as printed in the Congressional Record, vol. 162, no. 67, April 29, 2016, page H2150.

Printed hearings 2

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
—LEGISLATION TO IMPROVE AND SUSTAIN THE MEDICARE PROGRAM66 pagesWays and Means CommitteeJun 8, 2016
Serial No. 114-146THE OBAMA ADMINISTRATION'S MEDICARE DRUG EXPERIMENT: THE PATIENT AND DOCTOR PERSPECTIVE279 pagesEnergy and Commerce CommitteeMay 17, 2016

Titles 1

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Apr 29, 2016Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.